港股異動 | 耐世特(1316.HK)漲近6% 券商指其2021年經營穩步恢復
格隆匯6月1日丨耐世特(1316.HK)拉昇漲近6%,報10.1港元,成交額超1億港元,總市值為254億港元。興業證券發報吿稱,維持耐世特“買入”評級,目標價16.22港元。報吿中稱,公司2021年經營穩步恢復。伴隨2020年新項目在2021年貢獻完整收入以及2021年新項目投產,公司業績有望繼續實現穩健增長。該行認為,芯片短缺對公司影響較為有限。另外,公司的高負載EPS優勢受益汽車電動化、高端化邏輯正在逐步兑現。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.